Sonoma Pharmaceuticals Q4 EPS $(0.07) Up From $(0.31) YoY, Sales $3.44M Miss $3.98M Estimate
Sonoma Pharmaceuticals Q4 EPS $(0.07) Up From $(0.31) YoY, Sales $3.44M Miss $3.98M Estimate
Sonoma pharmaceuticals第四季度每股收益爲$(0.07)，同比從$(0.31)上升，銷售額爲$3.44M，低於$3.98M的預期。
Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly losses of $(0.07) per share. This is a 77.42 percent increase over losses of $(0.31) per share from the same period last year. The company reported quarterly sales of $3.44 million which missed the analyst consensus estimate of $3.98 million by 13.59 percent. This is a 14.10 percent increase over sales of $3.01 million the same period last year.
索諾瑪製藥（納斯達克股票代碼：SNOA）報告每股季度虧損0.07美元。與去年同期每股虧損0.31美元（0.31）相比，增長了77.42％。該公司公佈的季度銷售額爲344萬美元，比分析師普遍預期的398萬美元低13.59％。這比去年同期的301萬美元銷售額增長了14.10％。